PERMIDES - Personalized Medicine Innovation through Digital Enterprise Solutions
AdVancing precision medicine in the digital age requires solutions developed in the IT and software sector, e.g. big data, machine learning, IT security, data protection, and cross-enterprise collaboration. The PERMIDES project aims at bringing together SMEs from the bio-pharmaceutical and IT sector to advance precision medicine through the development of novel digital solutions along the biopharmaceutical value chain. SMEs participating in the PERMIDES project can increase competitiveness and benefit from an innovation voucher scheme that will provide up to EUR 60,000 per project. About 90 innovation projects will be supported by the voucher scheme.
How can you as a SME benefit?
SMEs from the biopharmaceutical sector get access to relevant partners from the IT sector. The IT companies can develop and implement tailored digital solutions to improve business and product development processes. The costs incurred for this purpose by the IT partner will be covered by means of consulting, prototyping and customised solution vouchers totalling up to EUR 60,000. The biopharmaceutical company may also benefit from new products and applications developed by the IT company within the framework of the joint project.
SMEs from the IT sector get access to partners and new customers from the biopharmaceutical sector to apply and adapt their solutions to SMEs developing novel personalized medicine products. Innovation vouchers will cover their expenses, and the knowledge gained during these projects may create new products and business opportunities.
Which dates are important?
Autumn 2016: Workshops in each country in autumn 2016
Spring 2017: Calls for Innovation Projects published, max. 3-month review time, open calls until spring 2018. Matchmaking events and PERMIDES Platform for partner identification will be offered from spring 2017 onwards
Summer 2017: First innovation voucher funding granted
How is the project funded?
The PERMIDES consortium was awarded EUR 4.8 million from the EU’s Horizon2020 programme. 75% of the total amount, i.e. EUR 3.7 million, will directly benefit SMEs, with EUR 3 million to be handed out via innovation vouchers.
Who is driving the project?
Six clusters from three countries and two industrial IT partners form the PERMIDES consortium. The partners will work closely with the SMEs from their clusters to maximize the impact for the SMEs.
• Software-Cluster c/o CyberForum e.V. (Coordinator) (DE)
• Ci3 - Cluster für Individualisierte ImmunIntervention e.V. (DE)
• Oslo Cancer Cluster S.A (NO)
• NCE Smart Energy Markets c/o Smart Innovation Østfold AS (NO)
• Oncotyrol Center for Personalized Cancer Medicine GmbH (AT)
• Business Upper Austria OÖ Wirtschaftsagentur GmbH (AT)
• intelligent views GmbH (DE)
• NETSYNO Software GmbH (DE)
Cluster für Individualisierte ImmunIntervention (Ci3) e. V.
Phone: +49 6131 21 69 771
- 9. August 2016